ERBB2 and breast carcinoma: Considered to play a role in the biologic behavior or pathogenesis of human breast cancer, the amplification of the HER-2/neu gene is now regarded as an established predictive [3] and prognostic [4] marker for breast cancer, particularly for the management of advanced breast cancer.